Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 TrialDeepak L. Bhatt, William Downey, Muthiah Vaduganathan et al.|The Lancet|2022Cited by 181
Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".Dean J. Kereiakes, Mauricio G. Cohen, Lawrence A. Barr et al.|PubMed|2000Cited by 43